Filgrastim, a pharmaceutical analog of granulocyte colony-stimulating factor (G-CSF), is commonly used to prevent infection in immunocompromised cancer patients by stimulating production of neutrophils by the bone marrow [3]. Here, CSF3 is linked to infection.